Health & Wellbeing

• Can We Repurpose Existing Drugs to Fight Aging? New Research Maps a Network-Medicine Path
• Longevity Science's New Frontier: Blood Proteins, Senescent Cells, and the Quest to Predict — and Delay — Death
• FTC Cracks Down on Pharmacy Benefit Middlemen: What the Caremark Settlement Means for Drug Prices and Consumers
• Trump Pardons Clean Air Act Violators as Administration Continues Environmental Rollbacks
• Life on GLP-1 drugs: Patients describe fewer cravings, side effects, stigma and access barriers
• Medicare Fraud Crackdown Claims 7,100% Surge in Transplant Claims — What's Behind the Numbers?
• Google Embeds AI Everywhere: From Classrooms to Chromebooks, What Mass AI Integration Means for Students and Consumers
• Blood Test Can Predict Alzheimer's Years Early—But Who Gets to Benefit?
• White House Messaging Blitz Frames Court Wins and Policy Rollouts as Populist Victories — A Closer Look at the Claims
• NIH Proposes Capping Researcher Grants: Could It Democratize — or Disrupt — Global Health Science?
• Health Policy's Evidence Gap: Why Short-Term Politics Keep Undermining Long-Term Public Health
• The 2026 Senate Map: Can Democrats Flip the Chamber, and What Would It Mean for Policy?